The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two prognostic populations of ovarian cancer patients defined by CA125 modeled kinetic parameter KELIM (AGO-OVAR 7 & 9; ICON 7 AGO/GINECO/ MRC CTU/GCIG trials).
 
Benoit You
Expert Testimony - AstraZeneca; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Roche
 
Olivier Colomban
No Relationships to Disclose
 
Gilles Freyer
No Relationships to Disclose
 
Alexandra Leary
Honoraria - AstraZeneca; PharmaMar
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Gamma Medica; PharmaMar
Research Funding - Roche
Travel, Accommodations, Expenses - PharmaMar
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; PharmaMar; Roche
Consulting or Advisory Role - Abbvie; Amgen; Pfizer
 
Alain Lortholary
Honoraria - AstraZeneca
 
Anne Claire Hardy Bessard
No Relationships to Disclose
 
Jacobus Pfisterer
Honoraria - Amgen; AstraZeneca; PharmaMar; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Roche Pharma AG (Inst); Roche Pharma AG (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Andreas Du Bois
Consulting or Advisory Role - AstraZeneca; Mundipharma; Pfizer; Pharmamar; Roche/Genentech
 
Christian Kurzeder
No Relationships to Disclose
 
Alexander Burges
Honoraria - AstraZeneca; Roche
 
Michel Tod
No Relationships to Disclose